Table 5

The HR of CKD in 2338 patients with schizophrenia for comorbidities and NSAIDs use during the 3-year follow-up period

VariableNumber of patientsCrude HR
(95% CI)
Adjusted HR*
(95% CI)
Adjusted HR†
(95% CI)
Adjusted HR‡
(95% CI)
Comorbidity
Hypertension420
 <65 years old2931111
 ≥65 years old1272.00 (1.23 to 3.25)§1.85 (1.13 to 3.03)§1.59 (0.96 to 2.63)1.54 (0.93 to 2.56)
Diabetes mellitus218
 <65 years old1731111
 ≥65 years old453.83 (2.06 to 7.12)¶3.66 (1.93 to 6.96)¶2.56 (1.26 to 5.16)§2.52 (1.25 to 5.09)§
Dyslipidaemia272
 <65 years old2361111
 ≥65 years old362.52 (1.13 to 5.65)2.54 (1.09 to 5.92)§1.78 (0.76 to 4.15)1.90 (0.80 to 4.53)
Heart disease343
 <65 years old2471111
 ≥65 years old962.53 (1.50 to 4.30)¶2.46 (1.44 to 4.20)¶1.69 (0.96 to 2.99)1.70 (0.96 to 3.00)
Medication
NSAIDs use960
 <65 years old8351111
 ≥65 years old1252.82 (1.84 to 4.30)¶2.82 (1.84 to 4.30)¶1.83 (1.13 to 2.97)§1.83 (1.13 to 2.97)§
  • *Adjusted HR Adjusted for NSAIDs use.

  • †Adjusted HR Adjusted for hypertension, diabetes mellitus, dyslipidaemia and heart disease.

  • ‡Adjusted HR Adjusted for hypertension, diabetes mellitus, dyslipidaemia, heart disease and NSAIDs use.

  • §p<0.05 for comparison between patients with two groups.

  • ¶p<0.001 for comparison between patients with two groups.

  • NSAIDs, non-steroidal anti-inflammatory drugs.